A system including a diagnostic-quality CT scanner for imaging a patient, the diagnostic-quality CT scanner having an imaging isocenter and a radiation therapy device positioned adjacent the diagnostic-quality CT scanner, the radiation therapy device including a gantry carrying a radiation therapy beam source and having a radiation therapy isocenter separate from the imaging isocenter of the diagnostic-quality CT scanner. The system including a couch configured to position the patient for imaging and for radiation therapy by translating the patient between the diagnostic quality CT scanner and the radiation therapy device.

A radiation therapy system includes a radiation source capable of generating a beam of radiation; a magnetic resonance imaging (MRI) apparatus comprising at least one radiofrequency detector coil; and an electrically grounded dielectric material between the radiation source and the radiofrequency detector coil for shielding the at least one radiofrequency detector coil from the beam of radiation. Also disclosed is a radiofrequency detector coil for a magnetic resonance imaging (MRI) apparatus sheathed at least in part by a dielectric material that is adapted to be electrically grounded.

A radiotherapy device, a control driving method thereof, and a radiotherapy system are disclosed. The radiotherapy device includes a radioactive source apparatus, the radioactive source apparatus includes a source carrier and a collimator, the source carrier is provided with a plurality of radioactive sources thereon, an angle of the plurality of radioactive sources in a longitude direction is within a preset angle range; the collimator is provided with a collimating hole thereon, and radiation beams emitted from the plurality of radioactive sources intersect at a common focus after passing through the collimating hole on the collimator.

A radiotherapy device and a control driving method thereof are provided. The radiotherapy device includes a radiation source apparatus, the radiation source apparatus includes a plurality of radiation sources and a collimator, and source points of the plurality of radiation sources are within a preset included angle range in a longitude direction. The preset included angle range is 5 to 60 degrees. The collimator is provided with a plurality of collimating hole groups, and an included angle of each of the collimating hole groups in the longitude direction is within the preset included angle range; and each of the collimating hole groups includes a plurality of collimating holes, and radiation beams emitted from the plurality of radiation sources intersect at a common focus after passing through the collimating holes of the collimating hole groups.

An adhesive having shielding properties can provide a bonded part of a structure with neutron shielding properties. The shield adhesive having neutron shielding properties contains a lithium fluoride powder having lithium fluoride purity of 99% or more. The shield adhesive can be a two-pack curable adhesive and contain an epoxy resin as a main component. This shield adhesive can be a two-liquid curing type adhesive, which may contain an epoxy resin as a main component and may contain a modified silicone resin as a curing agent.

Provided is a focusing head, including: a cartridge configured to carry a plurality of radiation sources; a shielding roller with the cartridge therein; a first driving assembly connected to the cartridge and configured to drive the cartridge to rotate; and a second driving assembly connected to the shielding roller and configured to drive the shielding roller to rotate.

A photon therapy delivery system can deliver radiation therapy to a patient via a photon beam. The system can utilize a controller configured to facilitate delivery of radiation therapy via a photon beam and also a particle beam. This can include receiving radiation therapy beam information for radiation therapy treatment of a patient utilizing the particle beam and photon beam. Also, patient magnetic resonance imaging (MRI) data can be received during the radiation therapy treatment. Utilizing the patient MRI data, real-time calculations of a location of dose deposition for the particle beam and for the photon beam can be determined taking into account interaction properties of soft tissues through which the particle beam passes.

A radiography and radiotherapy apparatus comprises a body unit, a gantry configured to rotate relative to the body unit, a treatment table on which an object is placed and configured to slide into holes formed in the body unit and the gantry and move in a vertical direction, a gantry driving part configured to rotate the gantry, a radiation irradiation part mounted on the gantry and configured to irradiate radiation toward the object, an image detector mounted to face the radiation irradiation part in the gantry and configured to detect the radiation irradiated from the radiation irradiation part, and a beam stopper provided at a lower end of the image detector and configured to block the radiation.

A radiation beam delivery apparatus is provided that utilizes a plurality of treatment heat actuators to provide accurate positioning of a treatment head relative to the patient. The apparatus fallows for six degrees of freedom for the treatment heat and further provides for a patient support that can be Independently adjusted along a patient-s x axis, a y-axis, and roll and pitch movements.

A flexible brachytherapy device includes a bioresorbable carrier matrix structure comprising a plurality of radio-isotope particles and having opposite first and second surfaces. The bioresorbable carrier matrix structure degrades, when implanted at a wound site, at a rate such that the bioresorbable carrier matrix structure has a half-life that is longer than a half-life of the plurality of radio-isotope particles. A hydrophilic substrate located adjacent to the first surface of the bioresorbable carrier matrix structure degrades, when implanted at the wound site, at a rate faster than the bioresorbable carrier matrix structure. A hydrogel substrate located adjacent to the second surface of the bioresorbable carrier matrix structure shields radioactivity and degrades at a rate such that the hydrogel substrate has a half-life that is longer than the half-life of the plurality of radio-isotope particles.